Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (787) 787
cefoxitin - therapeutic use (714) 714
female (529) 529
adult (393) 393
male (391) 391
middle aged (322) 322
science & technology (269) 269
life sciences & biomedicine (245) 245
aged (227) 227
biological and medical sciences (214) 214
medical sciences (212) 212
bacterial infections - drug therapy (202) 202
cefoxitin (188) 188
abridged index medicus (184) 184
pharmacology. drug treatments (172) 172
cefoxitin - administration & dosage (159) 159
cefoxitin - pharmacology (155) 155
antibiotics. antiinfectious agents. antiparasitic agents (154) 154
surgical wound infection - prevention & control (152) 152
anti-bacterial agents - therapeutic use (149) 149
antibacterial agents (148) 148
clinical trials as topic (148) 148
premedication (145) 145
antibiotics (142) 142
adolescent (139) 139
microbial sensitivity tests (138) 138
cefoxitin - adverse effects (134) 134
prospective studies (132) 132
random allocation (129) 129
infectious diseases (127) 127
microbiology (118) 118
animals (115) 115
cephalosporins - therapeutic use (109) 109
anti-bacterial agents - pharmacology (98) 98
pharmacology & pharmacy (91) 91
pregnancy (87) 87
drug resistance (83) 83
bacteria (80) 80
drug evaluation (80) 80
drug therapy, combination (80) 80
drug resistance, microbial (78) 78
double-blind method (74) 74
child (69) 69
infections (69) 69
research article (69) 69
postoperative complications - prevention & control (66) 66
bacterial infections - prevention & control (65) 65
cephamycins - therapeutic use (64) 64
antimicrobial agents (61) 61
bacteria - drug effects (59) 59
bacterial infections - microbiology (56) 56
clindamycin - therapeutic use (49) 49
ampicillin - therapeutic use (48) 48
biochemical phenomena, metabolism, and nutrition (48) 48
drug therapy, combination - therapeutic use (48) 48
gentamicins - therapeutic use (48) 48
ampicillin (46) 46
cefamandole - therapeutic use (46) 46
cefoxitin - metabolism (46) 46
penicillin (45) 45
polycyclic compounds (44) 44
staphylococcus infections (43) 43
laboratories (42) 42
bacterial infections and mycoses (41) 41
cesarean section (41) 41
child, preschool (41) 41
metronidazole - therapeutic use (41) 41
acute disease (40) 40
antimicrobial resistance (40) 40
bacterial diseases (40) 40
escherichia coli infections - drug therapy (40) 40
mice (40) 40
urinary tract infections - drug therapy (40) 40
cefotaxime - therapeutic use (39) 39
cefotetan - therapeutic use (39) 39
e coli (39) 39
time factors (39) 39
infant (38) 38
antibiotic prophylaxis (37) 37
escherichia coli - drug effects (37) 37
pelvic inflammatory disease - drug therapy (37) 37
cephalosporins (36) 36
cefazolin - therapeutic use (35) 35
cephalosporins - pharmacology (35) 35
drug resistance in microorganisms (35) 35
antibiotic resistance (34) 34
pathogens (34) 34
aged, 80 and over (33) 33
cefotetan (33) 33
hospitals (33) 33
hysterectomy (33) 33
kinetics (33) 33
methicillin (33) 33
risk factors (33) 33
staphylococcus aureus (33) 33
bacterial proteins - genetics (32) 32
surgery (32) 32
cefoxitin - blood (31) 31
injections, intravenous (31) 31
medicine (31) 31
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (843) 843
Japanese (62) 62
Italian (34) 34
German (32) 32
French (21) 21
Spanish (14) 14
Portuguese (6) 6
Chinese (3) 3
Czech (3) 3
Bulgarian (2) 2
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Spectrum and treatment of anaerobic infections
by Brook, Itzhak
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, ISSN 1341-321X, 2015, Volume 22, Issue 1, pp. 1 - 13
Hematology, Oncology and Palliative Medicine | Infection | Anaerobes | Antimicrobial resistance | Antibiotics | Bacteroides fragilis | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Cefoxitin - therapeutic use | Penicillins - therapeutic use | Bacterial Infections - drug therapy | Humans | Minocycline - analogs & derivatives | Anti-Infective Agents - therapeutic use | Drug Resistance, Bacterial | Chloramphenicol - therapeutic use | Bacteria, Anaerobic - pathogenicity | Clindamycin - therapeutic use | Carbapenems - therapeutic use | Metronidazole - therapeutic use | Minocycline - therapeutic use | beta-Lactamase Inhibitors - therapeutic use | Bacterial Infections - microbiology | Bacteria, Anaerobic - growth & development | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Antibiotic Treatment of Mycobacterium abscessus Lung Disease: A Retrospective Analysis of 65 Patients
by Jeon, Kyeongman and Kwon, O Jung and Lee, Nam Yong and Kim, Bum-Joon and Kook, Yoon-Hoh and Lee, Seung-Heon and Park, Young Kil and Kim, Chang Ki and Koh, Won-Jung
American journal of respiratory and critical care medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Pharmacology. Drug treatments | Biological and medical sciences | Intensive care medicine | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy
by Fong, Zhi Ven and McMillan, Matthew T and Marchegiani, Giovanni and Sahora, Klaus and Malleo, Giuseppe and De Pastena, Matteo and Loehrer, Andrew P and Lee, Grace C and Ferrone, Cristina R and Chang, David C and Hutter, Matthew M and Drebin, Jeffrey A and Bassi, Claudio and Lillemoe, Keith D and Vollmer, Charles M and Fernandez-del Castillo, Carlos
JAMA surgery, ISSN 2168-6254, 05/2016, Volume 151, Issue 5, pp. 432 - 439
Life Sciences & Biomedicine | Surgery | Science & Technology | Perioperative Care | Cefoxitin - therapeutic use | Enterococcus faecalis - drug effects | Patient Readmission | Escherichia coli - drug effects | Humans | Drug Resistance, Bacterial | Sulbactam - therapeutic use | Male | Antibiotic Prophylaxis | Pancreaticoduodenectomy - adverse effects | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Streptococcus pneumoniae - isolation & purification | Surgical Wound Infection - drug therapy | Metronidazole - therapeutic use | Bile - microbiology | Female | Ampicillin - therapeutic use | Streptococcus pneumoniae - drug effects | Cefazolin - therapeutic use | Staphylococcus aureus - isolation & purification | Surgical Wound Infection - prevention & control | Enterococcus faecalis - isolation & purification | Home Care Services | Escherichia coli - isolation & purification | Anti-Bacterial Agents - pharmacology | Surgical Wound Infection - microbiology | Staphylococcus aureus - drug effects | Stents - adverse effects
Journal Article
Details down arrow
4. Full Text Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
by Kim, Tae Ho and Hanh, Bui Thi Bich and Kim, Guehye and Lee, Da-Gyum and Park, June-Woo and Lee, So Eui and Kim, Jae-Sung and Kim, Byoung Soo and Ryoo, Sungweon and Jo, Eun-Kyeong and Jang, Jichan
Molecules (Basel, Switzerland), ISSN 1420-3049, 12/2019, Volume 24, Issue 24, p. 4511
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Cell Line | Mycobacterium abscessus - classification | Thiostrepton - pharmacology | Humans | Thiostrepton - therapeutic use | Zebrafish | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Macrophages - metabolism | Animals | Mycobacterium Infections, Nontuberculous - microbiology | Anti-Bacterial Agents - chemistry | Mycobacterium Infections, Nontuberculous - metabolism | Inflammation Mediators - metabolism | Macrophages - drug effects | Anti-Bacterial Agents - pharmacology | Molecular Structure | Mycobacterium abscessus - genetics | Mycobacterium abscessus - drug effects | Cytokines - biosynthesis | Macrophages - immunology | Mycobacterium Infections, Nontuberculous - drug therapy | Disease Models, Animal | Clarithromycin | Antimicrobial activity | Amikacin | Body piercing | Infections | Macrophages | Drug resistance | Cancer therapies | Antiinfectives and antibacterials | Lipopolysaccharides | Streptococcus infections | Tumor necrosis factor-TNF | Cytokines | β-Lactam antibiotics | Staphylococcus infections | Antimicrobial agents | Thorax | Tumor necrosis factor-α | Cefoxitin | Gene expression | Infectious diseases | Tuberculosis | Thiostrepton | Interleukin 10 | Monoclonal antibodies | Binding sites | Imipenem | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus
by Koh, Won-Jung and Jeon, Kyeongman and Lee, Nam Yong and Kim, Bum-Joon and Kook, Yoon-Hoh and Lee, Seung-Heon and Park, Young Kil and Kim, Chang Ki and Shin, Sung Jae and Huitt, Gwen A and Daley, Charles L and Kwon, O. Jung
American journal of respiratory and critical care medicine, ISSN 1073-449X, 02/2011, Volume 183, Issue 3, pp. 405 - 410
Mycobacterium massiliense | Treatment outcome | Clarithromycin | Mycobacterium abscessus | Nontuberculous mycobacteria | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Emergency and intensive care: metabolism and nutrition disorders. Enteral and parenteral nutrition | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Sputum - microbiology | Cefoxitin - therapeutic use | Nontuberculous Mycobacteria - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Treatment Outcome | Clarithromycin - therapeutic use | Mycobacterium Infections, Nontuberculous - diagnosis | Microbial Sensitivity Tests | Amikacin - therapeutic use | Mycobacterium Infections, Nontuberculous - microbiology | Antibiotics, Antitubercular - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea
by Lee, J.H and Subhadra, B and Son, Y.‐J and Kim, D.H and Park, H.S and Kim, J.M and Koo, S.H and Oh, M.H and Kim, H.‐J and Choi, C.H
Letters in applied microbiology, ISSN 0266-8254, 01/2016, Volume 62, Issue 1, pp. 84 - 90
community UTI | uropathogenic Escherichia coli | virulence | antimicrobial resistance | children | phylogenetic group | Phylogenetic group | Uropathogenic Escherichia coli | Antimicrobial resistance | Children | Community UTI | Virulence | Life Sciences & Biomedicine | Microbiology | Biotechnology & Applied Microbiology | Science & Technology | Escherichia coli Infections - drug therapy | Cefoxitin - therapeutic use | Virulence Factors - genetics | Humans | Escherichia coli Infections - microbiology | Chloramphenicol - therapeutic use | Phylogeny | Urinary Tract Infections - drug therapy | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Uropathogenic Escherichia coli - drug effects | Uropathogenic Escherichia coli - isolation & purification | Uropathogenic Escherichia coli - pathogenicity | Drug Resistance, Multiple, Bacterial | Escherichia coli Proteins - genetics | Urinary Tract Infections - microbiology | Child | Ceftazidime - therapeutic use | Republic of Korea | Drug resistance in microorganisms | Analysis | Urinary tract infections | Virulence (Microbiology) | Health aspects | Antibacterial agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase
by Raphaël Lepeule and Etienne Ruppé and Patrick Le and Laurent Massias and Françoise Chau and Amandine Nucci and Agnès Lefort and Bruno Fantin
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2012, Volume 56, Issue 3, pp. 1376 - 1381
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Urinary tract. Prostate gland | Infectious diseases | Bacterial diseases | Human bacterial diseases | Urinary system involvement in other diseases. Miscellaneous | Pharmacology. Drug treatments | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Bacterial diseases of the urinary system | Antibiotics. Antiinfectious agents. Antiparasitic agents | Conjugation, Genetic | Imipenem - therapeutic use | Cefoxitin - therapeutic use | Carbapenems - administration & dosage | Escherichia coli - drug effects | Humans | Ceftriaxone - pharmacology | Bacterial Load - drug effects | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Carbapenems - pharmacology | beta-Lactamases - genetics | Ceftriaxone - administration & dosage | Female | Urinary Tract Infections - microbiology | Urinary Bladder - microbiology | beta-Lactamases - metabolism | Disease Models, Animal | Escherichia coli Infections - drug therapy | Imipenem - administration & dosage | Kidney - drug effects | Cefoxitin - administration & dosage | Drug Administration Schedule | Escherichia coli Infections - microbiology | Mutation Rate | Imipenem - pharmacology | Urinary Tract Infections - drug therapy | Kidney - microbiology | beta-Lactams - pharmacology | Animals | Ceftriaxone - therapeutic use | Carbapenems - therapeutic use | Escherichia coli - genetics | Plasmids | Urinary Bladder - drug effects | Anti-Bacterial Agents - pharmacology | Mice | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus | Experimental Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Rationale for Eliminating Staphylococcus Breakpoints for β-Lactam Agents Other Than Penicillin, Oxacillin or Cefoxitin, and Ceftaroline
by Jennifer Dien Bard and Janet A. Hindler and Howard S. Gold and Brandi Limbago
Clinical infectious diseases, ISSN 1058-4838, 5/2014, Volume 58, Issue 9, pp. 1287 - 1296
Microbial sensitivity tests | Cephalosporins | Penicillin | Methicillin resistant staphylococcus aureus | Infections | Skin | Joints | Staphylococcus | Staphylococcus aureus | Blood | MEDICAL MICROBIOLOGY | β-lactams and Staphylococcus | CLSI breakpoints | Staphylococcus susceptibility | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Cefoxitin - therapeutic use | Staphylococcal Infections - drug therapy | beta-Lactam Resistance | Penicillins - therapeutic use | United States | Humans | Oxacillin - pharmacology | Staphylococcus - drug effects | Oxacillin - therapeutic use | Cefoxitin - pharmacology | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | beta-Lactams - pharmacology | Anti-Bacterial Agents - pharmacology | Penicillins - pharmacology | beta-Lactams - therapeutic use | Cephalosporins - pharmacology | United States Food and Drug Administration | Care and treatment | Oxacillin | Usage | Diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Klebsiella pneumoniae Outer Membrane Porins OmpK35 and OmpK36 Play Roles in both Antimicrobial Resistance and Virulence
by Yu-Kuo Tsai and Chang-Phone Fung and Jung-Chung Lin and Jiun-Han Chen and Feng-Yee Chang and Te-Li Chen and L. Kristopher Siu
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2011, Volume 55, Issue 4, pp. 1485 - 1493
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Cefoxitin - therapeutic use | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Porins - metabolism | Molecular Sequence Data | Male | Phagocytosis - genetics | Genetic Complementation Test | Cefoxitin - pharmacology | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Virulence - genetics | Klebsiella pneumoniae - genetics | Klebsiella pneumoniae - metabolism | Cephalosporins - pharmacology | Thienamycins - therapeutic use | Phagocytosis - drug effects | Klebsiella Infections - drug therapy | Porins - genetics | Bacterial Proteins - genetics | Klebsiella Infections - genetics | Thienamycins - pharmacology | Sequence Analysis, DNA | Animals | Klebsiella pneumoniae - pathogenicity | Virulence - physiology | Bacterial Proteins - metabolism | Mice | Mice, Inbred BALB C | Drug Resistance, Multiple, Bacterial - genetics | Ceftazidime - therapeutic use | Index Medicus | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Pelvic Inflammatory Disease
by Brunham, Robert C and Gottlieb, Sami L and Paavonen, Jorma
The New England journal of medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 21, pp. 2039 - 2048
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-Bacterial Agents - therapeutic use | Cefoxitin - therapeutic use | Pelvic Inflammatory Disease - drug therapy | Doxycycline - therapeutic use | Pelvic Inflammatory Disease - prevention & control | Humans | Infertility, Female - etiology | Pelvic Inflammatory Disease - diagnosis | Female | Pelvic Inflammatory Disease - etiology | Pregnancy | Birth control | Sexually transmitted diseases--STD | Pain | Womens health | Pathogenesis | Infertility | Infections | Pelvic inflammatory disease | Inflammatory diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights